Genmab A (GMAB) Beginning Cash Balance (2022 - 2024)

Genmab A (GMAB) has reported Beginning Cash Balance for 3 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Beginning Cash Balance fell 0.96% year-over-year to $1.3 billion; the trailing twelve-month figure through Dec 2024 stood at $1.3 billion (down 0.96% YoY), and the FY2024 full-year result was $1.3 billion, down 0.96% from the prior year.
• Beginning Cash Balance retreated to $1.3 billion in Q4 2024 per GMAB's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Beginning Cash Balance topped out at $1.4 billion in Q4 2023 and bottomed at $824.0 million in Q4 2022.
• Historically, Beginning Cash Balance has averaged $1.2 billion across 3 years, with a median of $1.3 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Beginning Cash Balance jumped 64.94% in 2023, then slipped 0.96% in 2024.
• Over 3 years, Beginning Cash Balance stood at $824.0 million in 2022, then surged by 64.94% to $1.4 billion in 2023, then fell by 0.96% to $1.3 billion in 2024.
• According to Business Quant data, Beginning Cash Balance over the past three periods registered $1.3 billion, $1.4 billion, and $824.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.